SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Paramount Skydance Corp. is a next-generation global media and entertainment company that engages in providing content creation and distribution services. It operates through the following business segments: Studios, Direct-to-Consumer, and TV Media. Its portfolio unites brands including Paramount Pictures, Paramount Television, CBS, CBS News, Nickelodeon, MTV, BET, Comedy Central, Showtime, Paramount Plus, Pluto TV, and Skydance’s Animation, Film, Television, Interactive/Games, and Sports divisions. The company is headquartered in New York, NY.

Paramount Skydance Corp. - Ordinary Shares - Class B

Settlements with a coalition of state attorneys general and the Writers Guild have cleared the antitrust challenge to Paramount Skydance's Warner Bros. Discovery acquisition, with management signaling the deal could close in roughly two weeks. The community is divided between bulls celebrating the cleared path and frustrated holders calling the stock's pullback a sell-the-news reaction, with some attributing the weakness to short-selling pressure and others to lingering deal uncertainty.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMD is trending after crossing $1 trillion in market capitalization for the first time on a near-10% surge to record highs, driven by bets that agentic AI tools like Meta's Muse will lift demand for its server CPUs. The community is split between bulls celebrating the milestone and short-squeeze momentum, and skeptics warning of stretched valuations, insider selling, and a potential pullback.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is trending after a Form 4 filing showed CEO Ryan Cohen purchased roughly 1.15 million additional shares on the open market, extending a cluster of insider buys that also included other executives and directors. Retail reaction is largely bullish, with traders hoping for a short squeeze and circulating an unverified theory that Roaring Kitty (Keith Gill) is signaling a return, while skeptics point to the muted price reaction and allege the stock is being suppressed.

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

Meta is rallying on rapid consumer adoption of its new Muse AI agent, which has topped U.S. app store charts and is being read as evidence that the company's heavy AI investment can translate into consumer revenue. Traders are split between bulls citing the Shopify agentic-commerce partnership and heavy call-option activity as confirmation of a breakout, and skeptics calling the move an overextended, hype- or squeeze-driven rally, with Amazon's decision to block Muse from its marketplace flagged as a key risk to the thesis.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is drawing heavy attention after founder Patrick Soon-Shiong teased a blockchain-based tokenized stock trading push at Nant following the SEC's new framework for tokenized securities, fueling speculation that IBRX shares could eventually be tokenized. Traders are split between bulls who see tokenization as a way to curb naked shorting and trap short sellers, and skeptics who view the tease as unconfirmed hype or a distraction from pending FDA and pipeline catalysts.

BlackBerry Ltd. engages in the provision of intelligent security software and services. It operates through the following segments: QNX, Secure Communications, and Licensing. The QNX segment includes development of safe and reliable software for embedded systems across technology-driven industries. The Secure Communications segment delivers operational resiliency with a government-grade portfolio of secure, certified solutions for mobile fortification, critical communications and crisis management. The Licensing segment focuses on management and monetization of the firm's global patent portfolio. The company was founded by Michael Lazaridis, James Laurence Balsillie, and Douglas E. Fregin on March 7, 1984 and is headquartered in Waterloo, Canada.

BlackBerry Ltd

BlackBerry shares are rallying ahead of the company's quarterly earnings report, with an RBC Capital note suggesting revenue, EBITDA and EPS may exceed consensus and Jim Cramer's 'buy' endorsement drawing heavy attention. The community is predominantly bullish on QNX and physical AI momentum into results, though some traders dismiss Cramer as a reverse indicator and plan to short any pop.

ProShares Trust - ProShares UltraPro QQQ 3x Shares

ProShares UltraPro QQQ

TQQQ is surging as the Nasdaq rallies to record highs on broad AI and tech momentum, with falling oil prices and short-covering adding fuel. Traders are divided between bulls riding the melt-up and bears calling it an overbought "rigged pump," warning that fresh Fed rate hikes, elevated Treasury yields, and still-high oil could set up a pullback.

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Novo Nordisk - ADR

Novo Nordisk A/S

Novo shares fell sharply following its Capital Markets Day, where management laid out long-term blockbuster-launch and pipeline-sales targets but guided to only mid-single-digit revenue growth through 2030, which traders read as unambitious given Eli Lilly's push in obesity drugs and the looming semaglutide patent cliff. The community is split between critics blaming management credibility and execution for the sell-off and bulls calling the stock oversold, with some speculating Novo will need major acquisitions to close the pipeline gap.

Tidal Trust II - YieldMax Semiconductor Portfolio Option Income ETF

YieldMax Semiconductor Portfolio Option Income ETF

CHPY is trending as the semiconductor income ETF rebounds from a sharp chip-sector-driven drawdown and its latest weekly distribution comes in far larger than traders expected after weeks of shrinking payouts. The community is split between income-focused holders celebrating the fatter check and critics arguing the distributions are largely return of capital that masks NAV erosion, while others note the fund simply tracks the semiconductor index it holds.

London-based Quant Network is set to revolutionise blockchain technology with the development of their blockchain operating system Overledger. The experienced team are determined to fulfil the original vision of the internet by creating an open trusted network for people, machines, and data to operate securely and safely.  Overledger -the first interoperable blockchain operating system that facilitates internet-scale development of decentralised, multi-chain applications. Overledger has the ability to unlock and distribute value and applications across current and future blockchains. It is an agnostic platform that connects the world's networks to blockchains and ensures you're not limited to any single a vendor or technology. Overledger is the only platform that facilitates the development of internet-scales development of decentralised, multi-chain applications.

Quant

Quant is trending as the token trades against a broader crypto-market pullback, with conversation centered on the Honeywell-backed Quantinuum Nasdaq IPO that shares the QNT name and confusion over whether the stock and the token are connected. Traders are split between viewing the move as unrelated IPO spillover and crediting token-specific catalysts such as its Robinhood listing, staking plans, and small fixed supply, while skeptics dismiss the token as overhyped.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Universe Pharmaceuticals (UPC) Stock Soars Over 38% After-Hours: Here's What's Going On

Universe Pharmaceuticals Shares jumped after hours as eight investors disclosed ownership stakes following the company's patent acquisition.read more...

12 Health Care Stocks Moving In Monday's Intraday Session

Gainers

Universe Pharmaceuticals (NASDAQ:UPC) shares increased by 108.5% to $6.59 during Monday's regular session. The market value of their outstanding shares is at $2.0 million.
SL Science Holding (NASDAQ:SLBT)read more...

12 Health Care Stocks Moving In Monday's Pre-Market Session

Gainers

Universe Pharmaceuticals (NASDAQ:UPC) stock increased by 121.2% to $6.99 during Monday's pre-market session. The market value of their outstanding shares is at $2.0 million.
Supernus Pharmaceuticalsread more...

12 Health Care Stocks Moving In Friday's After-Market Session

Gainers

Universe Pharmaceuticals (NASDAQ:UPC) stock increased by 91.1% to $6.04 during Friday's after-market session. The company's market cap stands at $2.2 million.
BGM Group (NASDAQ:BGM) stock rose 11.63%read more...

12 Health Care Stocks Moving In Thursday's After-Market Session

Gainers

Seer (NASDAQ:SEER) stock moved upwards by 33.3% to $2.16 during Thursday's after-market session. The market value of their outstanding shares is at $89.6 million.
Universe Pharmaceuticals (NASDAQ:UPC)read more...

Gainers

Universe Pharmaceuticals (NASDAQ:UPC) stock moved upwards by 284.8% to $11.39 during Monday's regular session. The company's market cap stands at $1.9 million.
Decoy Therapeutics (NASDAQ:DCOY) sharesread more...

Universe Pharmaceuticals Expands Intellectual Property Strategy with Proposed Patent Portfolio Acquisition

Universe Pharmaceuticals (NASDAQ:UPC) announced that it has entered into a share purchase agreement to acquire Best Praise International Limited, a transaction that would add five China-based pharmaceutical patents to the company's intellectual property portfolio. The proposed acquisition, valued at approximately US$10.75 million and payable in Class A ordinary shares, is expected to broaden the company's research and development platform while expanding its focus beyond its existing traditional Chinese medicine business.

4 Sizzling Biotech and Healthcare Companies Reporting Strategic Milestones

As the second half of 2026 begins, a series of regulatory approvals, strategic acquisitions, clinical development milestones, and financing initiatives are highlighting continued activity across the biotechnology and healthcare sectors, as companies work to expand pipelines, strengthen balance sheets, and advance toward commercialization. $UPC, $NTHI, $DCOY, $VRDN

Gainers

Universe Pharmaceuticals (NASDAQ:UPC) stock moved upwards by 159.6% to $7.68 during Monday's pre-market session. The company's market cap stands at $1.9 million.
Decoy Therapeutics (NASDAQ:DCOY) stockread more...

Why Universe Pharmaceuticals Shares Are Trading Higher By Around 228%; Here Are 20 Stocks Moving Premarket

Universe Pharmaceuticals Inc (NASDAQ: UPC) surged 228.4% to $9.72 in pre-market trading after announcing acquisition of Best Praise International for $10.75 million.read more...

Universe Pharmaceuticals, Inc. is a pharmaceutical company. The firm is focused on the manufacturing, marketing, sales, and distribution of traditional Chinese medicine derivative products. It also sells biomedical drugs, medical instruments, traditional Chinese medicine Pieces, and dietary supplements manufactured by third-party pharmaceutical companies. The company was founded on March 2, 1998 and is headquartered in Ji'an, China.

Universe Pharmaceuticals INC - Ordinary Shares - Class A

UPC Stock Surges 288% After Hours — What’s Driving The Rally?

Equity

Bearish Sentiment

Rising interest rates

Surging bond yields

Oil/energy volatility

Trump/political risk

U.S. investors are navigating a stacked macro backdrop, with the Federal Reserve hiking rates for the first time since July 2023, the 10-year Treasury yield hitting 5.00% - its highest level since 2007 - and oil prices swinging between $94 and $105 a barrel amid the ongoing U.S.-Iran conflict and Saudi pipeline disruptions. What's the biggest risk to your portfolio right now? Vote and explain your reasoning in the comments.

With the Fed hiking rates for the first time since 2023, the 10-year Treasury yield near 5%, and oil prices swinging on the U.S.-Iran conflict, what&#39;s the biggest risk to your portfolio right now?

Stocktwits

With the Fed hiking rates for the first time since 2023, the 10-year Treasury yield near 5%, and oil prices swinging on the U.S.-Iran conflict, what's the biggest risk to your portfolio right now?

Current Price	$4.64
Prev Close	$4.86
Open	$4.86
Dividend Yield	0.00%
50-Day Moving Average	$4.82
Beta	0.01
Avg. Volume	1.43M
PE Ratio	-1.35

52-Week High	$17.96
52-Week Low	$2.00
Market Capitalization	$24.42M
EPS (Annual)	-$8.06
Price to Book	0.05
Revenue Per Employee	$82,679.32

Feed

News

Sentiment

Fundamentals

Info

UPC Fundamentals